Trial Profile
Role of CD36 in Nutrient Delivery and Its Dysfunction in African Americans
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 02 Dec 2022
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary) ; Arginine
- Indications Insulin resistance
- Focus Pharmacodynamics
- 25 Aug 2021 Status changed from active, no longer recruiting to completed.
- 15 Jan 2021 Planned End Date changed from 31 Dec 2020 to 1 Oct 2021.
- 15 Jan 2021 Planned primary completion date changed from 31 Dec 2020 to 1 Jul 2021.